VIVI — TempraMed Technologies Balance Sheet
0.000.00%
- CA$93.20m
- CA$99.36m
- $2.26m
Annual balance sheet for TempraMed Technologies, fiscal year end - December 31st, millions except per share.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | |
| Standards: | — | IFRS | IFRS |
| Status: | fx Preliminary | Final | Final |
| Cash and Equivalents | |||
| Cash and Short Term Investments | — | 0.053 | 0.021 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | — | 0.027 | 0.165 |
| Total Inventory | |||
| Total Current Assets | — | 0.263 | 0.266 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | — | 0.241 | 0.201 |
| Other Long Term Assets | |||
| Total Assets | — | 0.506 | 0.469 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | — | 1.55 | 3.52 |
| Long Term Debt | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Liabilities | — | 2.16 | 4.27 |
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | — | -1.65 | -3.8 |
| Total Liabilities & Shareholders' Equity | — | 0.506 | 0.469 |
| Total Common Shares Outstanding |